News & Events
Hematopoietic stem cell treatment in MS
Study shows improvement in neurological disability and other clinical outcomes
Independence is top concern as people age with MS
Nearly 2,000 people took part in the 2014 MS in focus online survey on ageing with MS
MS in focus on ageing
The final issue of MS in focus in the current format is now available to download in…
World MS Day website goes live
You can access the site in Arabic, English, French, Portuguese and Spanish
Oceans of Hope reaches Panama
The first round-the-world yacht trip crewed by people with MS is now in the Pacific
Early detection of nerve damage using the retina
OCT may be a good way to monitor the efficacy of both immunoprotective and neuroprotective therapies
Exploring the relationship between HIV and MS
Having HIV, and presumably being on antiretroviral therapy, may reduce the risk of developing MS
New biomarkers to predict progression in MS
Neurofilaments are a good way to monitor nerve damage and treatments in progressive MS
Natalizumab improves walking in relapsing-remitting MS
Natalizumab is associated with clinically meaningful improvements in walking speeds
Disease-modifying drugs may reduce disability progression in relapsing-remitting MS
Researchers found a lower risk of disability progression at the 10-year follow-up in the RRMS group compared…
Online cognitive training in Germany
DMSG’s training programme aims to help people with MS improve cognition functions
Working with MS Home in China
Abdelfatah Ibrahim’s visit focused on supporting a new MS/NMO group